Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

Author： Haarstad Helge   Lønning Per E.   Gundersen Stein   Wist Erik   Raabe Nils   Kvinnsland Stener  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.37, Iss.4, 1998-10, pp. : 365-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

By Buzdar A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 161-175

Springer Publishing Company

Access to resources Recommend Favorite

Postmenopausal Metastatic Breast Cancer: A Review of First-Line Treatment Options

By Assersohn L.   Johnston S.R.D.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 95-109

Adis International

Access to resources Recommend Favorite

First-Line Treatment of Metastatic Breast Cancer: Available Evidence and Current Recommendations

By Puglisi Fabio  

American Journal of Cancer, Vol. 5, Iss. 2, 2006-01 ,pp. : 99-110

Adis International

Access to resources Recommend Favorite

Gemcitabine: In Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

By Moen Marit D.   Wellington Keri  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

By Riemsma Rob  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 9-24

Springer Publishing Company

Access to resources Recommend Favorite